New York Life Investment Management’s Clarivate CLVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-34,533
Closed -$257K 951
2024
Q1
$257K Sell
34,533
-9,298
-21% -$77.7K ﹤0.01% 1310
2023
Q4
$406K Buy
43,831
+257
+0.6% +$1.9K ﹤0.01% 985
2023
Q3
$292K Buy
43,574
+22,238
+104% +$177K ﹤0.01% 1171
2023
Q2
$203K Buy
+21,336
New +$181K ﹤0.01% 1298

Other funds holding CLVT

New York Life Investment Management's CLVT Position: Q2 2024 in Review

New York Life Investment Management sold out of Clarivate (CLVT) in Q2 2024, closing a stake of 34,533 shares — an estimated $257K sold.

New York Life Investment Management first reported a position in CLVT in Q2 2023 and held it in 4 quarters. The position peaked at $406K in Q4 2023. 207 funds tracked by Wall St. Rank hold CLVT as of Q2 2024.

  • New York Life Investment Management reported no remaining Clarivate position as of Q2 2024 after selling out during the quarter.
  • New York Life Investment Management sold 34,533 Clarivate shares in Q2 2024, an estimated $257K.
  • New York Life Investment Management first reported a position in Clarivate in Q2 2023 and held it in 4 quarters.
  • New York Life Investment Management's Clarivate position peaked at $406K in Q4 2023.
  • 207 funds tracked by Wall St. Rank held Clarivate as of Q2 2024.

Based on New York Life Investment Management's 13F filing for Q2 2024, filed 5 Aug 2024.